Burrill & Co. is already nearing an exit on one of a dozen investments made from a new $505 million fund that had a second close last week.

G. Steven Burrill told BioCentury the undisclosed company already has "several term sheets and is working on an exit." He expects an acquisition will come roughly a year after the initial investment.